Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

84 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
GLS-driven glutamine catabolism contributes to prostate cancer radiosensitivity by regulating the redox state, stemness and ATG5-mediated autophagy.
Mukha A, Kahya U, Linge A, Chen O, Löck S, Lukiyanchuk V, Richter S, Alves TC, Peitzsch M, Telychko V, Skvortsov S, Negro G, Aschenbrenner B, Skvortsova II, Mirtschink P, Lohaus F, Hölscher T, Neubauer H, Rivandi M, Labitzky V, Lange T, Franken A, Behrens B, Stoecklein NH, Toma M, Sommer U, Zschaeck S, Rehm M, Eisenhofer G, Schwager C, Abdollahi A, Groeben C, Kunz-Schughart LA, Baretton GB, Baumann M, Krause M, Peitzsch C, Dubrovska A. Mukha A, et al. Among authors: skvortsov s. Theranostics. 2021 Jun 26;11(16):7844-7868. doi: 10.7150/thno.58655. eCollection 2021. Theranostics. 2021. PMID: 34335968 Free PMC article.
Screening and identification of molecular targets for cancer therapy.
Abdelmoez A, Coraça-Huber DC, Thurner GC, Debbage P, Lukas P, Skvortsov S, Skvortsova II. Abdelmoez A, et al. Among authors: skvortsov s. Cancer Lett. 2017 Feb 28;387:3-9. doi: 10.1016/j.canlet.2016.03.002. Epub 2016 Mar 8. Cancer Lett. 2017. PMID: 26968248 Review.
Therapy resistance mediated by cancer stem cells.
Steinbichler TB, Dudás J, Skvortsov S, Ganswindt U, Riechelmann H, Skvortsova II. Steinbichler TB, et al. Among authors: skvortsov s. Semin Cancer Biol. 2018 Dec;53:156-167. doi: 10.1016/j.semcancer.2018.11.006. Epub 2018 Nov 22. Semin Cancer Biol. 2018. PMID: 30471331 Review.
Therapy resistance mediated by exosomes.
Steinbichler TB, Dudás J, Skvortsov S, Ganswindt U, Riechelmann H, Skvortsova II. Steinbichler TB, et al. Among authors: skvortsov s. Mol Cancer. 2019 Mar 30;18(1):58. doi: 10.1186/s12943-019-0970-x. Mol Cancer. 2019. PMID: 30925921 Free PMC article. Review.
Cancer stem cells and their unique role in metastatic spread.
Steinbichler TB, Savic D, Dudás J, Kvitsaridze I, Skvortsov S, Riechelmann H, Skvortsova II. Steinbichler TB, et al. Among authors: skvortsov s. Semin Cancer Biol. 2020 Feb;60:148-156. doi: 10.1016/j.semcancer.2019.09.007. Epub 2019 Sep 12. Semin Cancer Biol. 2020. PMID: 31521746 Review.
Molecular heterogeneity in breast carcinoma cells with increased invasive capacities.
Negro G, Aschenbrenner B, Brezar SK, Cemazar M, Coer A, Gasljevic G, Savic D, Sorokin M, Buzdin A, Callari M, Kvitsaridze I, Jewett A, Vasileva-Slaveva M, Ganswindt U, Skvortsova I, Skvortsov S. Negro G, et al. Among authors: skvortsov s. Radiol Oncol. 2020 Feb 14;54(1):103-118. doi: 10.2478/raon-2020-0007. Radiol Oncol. 2020. PMID: 32061169 Free PMC article.
Simvastatin is effective in killing the radioresistant breast carcinoma cells.
Aschenbrenner B, Negro G, Savic D, Sorokin M, Buzdin A, Ganswindt U, Cemazar M, Sersa G, Skvortsov S, Skvortsova I. Aschenbrenner B, et al. Among authors: skvortsov s. Radiol Oncol. 2021 May 4;55(3):305-316. doi: 10.2478/raon-2021-0020. Radiol Oncol. 2021. PMID: 33939900 Free PMC article.
Erk1/2-Dependent HNSCC Cell Susceptibility to Erastin-Induced Ferroptosis.
Savic D, Steinbichler TB, Ingruber J, Negro G, Aschenbrenner B, Riechelmann H, Ganswindt U, Skvortsov S, Dudás J, Skvortsova II. Savic D, et al. Among authors: skvortsov s. Cells. 2023 Jan 16;12(2):336. doi: 10.3390/cells12020336. Cells. 2023. PMID: 36672272 Free PMC article.
84 results